Leading Professional Society for Computational Biology and Bioinformatics
Connecting, Training, Empowering, Worldwide

UPCOMING DEADLINES & NOTICES

  • Confirmation of Participation notices sent
    GLBIO 2024
    April 15, 2024
  • Late poster author notification
    RECOMB 2024
    April 19, 2024
  • Late registration deadline
    RECOMB 2024
    April 19, 2024
  • Last day for presenting and poster authors to complete registration *no extensions*
    GLBIO 2024
    April 22, 2024
  • Late poster submissions open (posters only)
    ISMB 2024
    April 22, 2024
  • Talks and posters submissions deadline
    ECCB 2024
    April 23, 2024
  • Registration deadline for organisers and speakers
    ECCB 2024
    April 30, 2024
  • Last day to upload ANY/ALL files to the virtual Platform
    GLBIO 2024
    May 06, 2024
  • Acceptance notification for talks and posters
    ECCB 2024
    May 08, 2024
  • Tech track proposal deadline (closes earlier if capacity is reached)
    ISMB 2024
    May 10, 2024
  • Early bird registration opens
    APBJC 2024
    May 10, 2024
  • Talk and/or poster acceptance notifications
    ISMB 2024
    May 13, 2024
  • Conference fellowship invitations sent for early abstract accepted talks and posters
    ISMB 2024
    May 13, 2024
  • (Conditional) Acceptance notification for proceedings
    ECCB 2024
    May 15, 2024
  • Registration deadline for talk presenting authors
    ECCB 2024
    May 15, 2024
  • CAMDA extended abstracts deadline
    ISMB 2024
    May 20, 2024
  • Late poster submissions deadline
    ISMB 2024
    May 20, 2024
  • Conference fellowship application deadline
    ISMB 2024
    May 20, 2024
  • Revised paper deadline
    ECCB 2024
    May 25, 2024
  • Tech track acceptance notification
    ISMB 2024
    May 31, 2024
  • Last day for discounted student hotel booking
    ISMB 2024
    May 27, 2024
  • Late poster acceptance notifications
    ISMB 2024
    May 28, 2024
  • CAMDA acceptance notification
    ISMB 2024
    May 30, 2024
  • Complete workshop/tutorial programme with speakers and schedule online
    ECCB 2024
    May 30, 2024
  • Conference fellowship acceptance notification
    ISMB 2024
    May 31, 2024
  • Tech track presentation schedule posted
    ISMB 2024
    May 31, 2024
  • Final acceptance notification for proceedings
    ECCB 2024
    May 31, 2024

Upcoming Conferences

A Global Community

  • ISCB Student Council

    dedicated to facilitating development for students and young researchers

  • Affiliated Groups

    The ISCB Affiliates program is designed to forge links between ISCB and regional non-profit membership groups, centers, institutes and networks that involve researchers from various institutions and/or organizations within a defined geographic region involved in the advancement of bioinformatics. Such groups have regular meetings either in person or online, and an organizing body in the form of a board of directors or steering committee. If you are interested in affiliating your regional membership group, center, institute or network with ISCB, please review these guidelines (.pdf) and send your exploratory questions to Diane E. Kovats, ISCB Chief Executive Officer (This email address is being protected from spambots. You need JavaScript enabled to view it.).  For information about the Affilliates Committee click here.

  • Communities of Special Interest

    Topically-focused collaborative communities

  • ISCB Member Directory

    Connect with ISCB worldwide

  • Green ISCB

    Environmental Sustainability Effort

  • Equity, Diversity, and Inclusion

    ISCB is committed to creating a safe, inclusive, and equal environment for everyone

Professional Development, Training, and Education

ISCBintel and Achievements

DETAILED AGENDA


Presentation slides are now available.  Click on the 'presentation slides' link located below each title.

Go directly to: Friday - December 6 | Saturday - December 7
WEDNESDAY – December 4, 2019
START TIME END TIME SESSION TYPE
04:00 pm 06:00 pm Registration
 
THURSDAY – December 5, 2019
START TIME END TIME SESSION TYPE
08:00 am 06:00 pm Registration
08:00 am 09:00 am Breakfast
09:00 am 09:45 am Keynote 1
KEVIN BRETONNEL COHEN, PhD
Director, Biomedical Text Mining Group
Computational Bioscience Program
University of Colorado School of Medicine, USA

• presentation slides

Two Existential Threats to Biomedical Text Mining...and How to Address Them with Natural Language Processing
09:45 am 09:55 am Withdrawn OP 01

Next Generation Sequencing as a preventive medicine tool. A Mexico-United States collaboration.

Presenting Author:
Gilberto de la Garza-Galvan, University of Texas Health Science Center at Houston
09:55 am 10:05 am OP 02
Enabling the next generation of microbiome science with QIIME 2

• presentation slides

Presenting Author:
Greg Caporaso, Northern Arizona University
10:05 am 10:15 am OP 03
Evolutionary Action is a unifying framework for assessing missense variant structures within and across phyla

• presentation slides

Presenting Author:

Nicholas Abel, Baylor College of Medicine
10:15 am 10:25 am OP 04
A toxicogenomics approach to identify liver and kidney injuries

• presentation slides

Presenting Author:
Patric Schyman, Biotechnology HPC Software Applications Institute (BHSAI)
10:25 am 10:45 am Break
10:45 am 11:15 am Keynote 2
JOSEPH ALLISON, PhD
Bioinformatic Scientist
SomaLogic, Inc.
Colorado, USA


• presentation slides

A Story of Proteomic Statistical Process Control at SomaLogic
11:15 am 11:25 am OP 05
Towards Automating Computational Phenotyping: Exploring the Trade-offs of Different Vocabulary Mapping Strategies

• presentation slides

Presenting Author:
Tiffany Callahan, University of Colorado Denver Anschutz Medical Campus- Computational Bioscience Program
11:25 am 11:35 pm OP 06
Open PBTA: Collaborative analysis of the Pediatric Brain Tumor Atlas

• presentation slides

Presenting Author:
Joshua Shapiro, Childhood Cancer Data Lab (Alex's Lemonade Stand Foundation)
11:35 pm 11:45 pm OP 07
Data Discovery Engine: A web-based toolset for maximizing data discoverability and promoting reusable data-sharing best practices

• presentation slides

Presenting Author:
Marco Cano, Scripps Research
11:45 pm 11:55 pm OP 08
Hypergraph Analytics for Computational Virology

• presentation slides

Presenting Author:
Cliff Joslyn, Pacific Northwest National Laboratory
12:00 pm 04:00 pm -->Ski Break
04:00 pm 04:30 pm Keynote 3
OLUWATOSIN OLUWADARE, PhD
Assistant Professor
Department of Computer Science and Bachelor of Innovation
College of Engineering and Applied Science
University of Colorado
USA

• presentation slides

3D Chromosome and Genome Structure Modeling
04:30 pm 04:40 pm OP 09
Containerized pipeline for the identification of compound heterozygous variants in trios

• presentation slides

Presenting Author:
Dustin Miller, Brigham Young University
04:40 pm 04:50 pm OP 10
The design of an interactive lung map for studying premalignant lesions in the lung over time

• presentation slides

Presenting Author:
Carsten Görg, Colorado School of Public Health
04:50 pm 05:00 pm OP 11
Apollo: an efficient tool to collaboratively refine and attribute genome-wide genomic annotationsc Annotations

• presentation slides

Presenting Author:
Nathan Dunn, University of California, Berkeley
05:00 pm 05:10 pm OP 12
An online end-to-end pipeline for virus phylogeography that leverages Natural Language Processing for finding host locations

• presentation slides

Presenting Author:
Matthew Scotch, Arizona State University
05:10 pm 05:30 pm Break
05:30 pm 05:40 pm OP 13
Evolutionary Action as a Tool for Quantifying Differentiation Across the Primate Family Tree

• presentation slides

Presenting Author:
Harley Peters, Baylor College of Medicine
05:40 pm 05:50 pm OP 14
Haplocravat: LD-based calculation built on top of a platform to annotate variants

• presentation slides

Presenting Author:
Ben Busby, Mountain Genomics/Johns Hopkins University
05:50 pm 06:00 pm OP 15
Characterizing the Regulatory Framework in an Aggressive Breast Cancer Phenotype: A Bayesian Regression-Based Enhancement

• presentation slides

Presenting Author:
George Acquaah-Mensah, Massachusetts College of Pharmacy & Health Sciences
06:30 pm 09:30 pm Dinner - Il Poggio
- top -
FRIDAY – December 6, 2019
START TIME END TIME SESSION TYPE
08:00 am 06:00 pm Registration
08:00 am 09:00 am Breakfast
09:00 am 09:45 am Keynote 4
JOYCE C. HO, PhD
Assistant Professor
Computer Science Department
Emory University
Georgia, USA

• presentation slides

Developing an Evidence Matching Framework Using Web-based Medical Literature
09:45 am 09:55 am OP 16
Discovering Subclones in Tumors Sequenced at Standard Depths

• presentation slides

Presenting Author:
Li Liu, Arizona State University
09:55 am 10:05 am OP 17
Pathogenic Synonymous Variants Are More Likely to Affect Codon Usage Biases than Benign Synonymous Variants

• presentation slides

Presenting Author:
Justin Miller, Brigham Young University
10:05 am 10:15 am OP 18
Map and model — moving from observation to prediction in toxicogenomics

• presentation slides

Presenting Author:
Wibke Busch, Helmholtz Centre for Environmental Research - UFZ
10:15 am 10:25 am OP 19
Combining the Evolutionary Trace Algorithm and Covariation Metrics Yields Improved Structural Predictions

• presentation slides

Presenting Author:
Daniel Konecki, Baylor College of Medicine
10:25 am 10:45 am Break
10:45 am 11:15 am Keynote 5
Joint Presentation:

NIMISHA SCHNEIDER, PhD
QuartzBio, part of
Precision for Medicine
Maryland, USA

TED FOSS, PhD
Director, Systems and Data Integration
Precision For Medicine
QuartzBio, part of Precision for Medicine
Maryland, USA

• presentation slides

Coupling Data-Driven and Mechanistic Modeling Approaches Through the Application of a Scalable, Knowledge-Driven Framework and High-Throughput Public Omics Data Sources
11:15 am 11:25 am OP 20
Toxicological Mechanistic Inference: Generating mechanistic explanations of adverse outcomes

• presentation slides

Presenting Author:
Ignacio Tripodi, University of Colorado, Boulder
11:25 am 11:35 pm OP 21
Giving credit where credit is due: How to make more meaningful connections between people and their roles, work, and impact

• presentation slides

Presenting Author:
Nicole Vasilevsky, Oregon Health & Science University
11:35 pm 11:45 pm OP 22
Nearest-neighbor Projected-Distance Regression to detect network interactions and control for confounders and multiple testing

• presentation slides

Presenting Author:
Trang Le, University of Pennsylvania
11:45 pm 11:55 pm OP 23
Deep learning enables in silico chemical-effect prediction

• presentation slides

Presenting Author:
Jana Schor, Helmholtz Centre for Environmental Research - UFZ
12:00 pm 04:00 pm -->Ski Break
04:00 pm 04:30 pm Keynote 6
JUSTIN GUINNEY, PhD
VP, Computational Oncology
Sage Bionetworks
Affiliate Associate Professor
University of Washington
Director, DREAM Challenges
Washington, USA


• presentation slides

The Model-to-Data Paradigm: Overcoming Data Access Barriers in Biomedical Competitions

04:30 pm 04:40 pm OP 24
Correlations and curses of dimensionality: optimizing k in nearest-neighbor feature selection

• presentation slides

Presenting Author:
Bryan Dawkins, University of Tulsa
04:40 pm 04:50 pm OP 25
Deep Learning based Multi-view model for deciphering gene regulatory keywords

• presentation slides

Presenting Author:
Pramod Bharadwaj Chandrashekar, Arizona State University
04:50 pm 05:00 pm OP 26
Identifying optimal mouse models for human asthma using a novel modeling approach

• presentation slides

Presenting Author:
Yihsuan Tsai, University of North Carolina at Chapel Hill
05:00 pm 05:10 pm OP 27
Bridging the Bioinformatics Knowledge Gap in the Pediatric Cancer Research Community with the Childhood Cancer Data Lab workshops

• presentation slides

Presenting Author:
Chante Bethell, Childhood Cancer Data Lab (Alex's Lemonade Stand Foundation)
05:10 pm 05:30 pm Break
05:30 pm 05:40 pm OP 28
Hetnet connectivity search provides rapid insights into how two biomedical entities are related

• presentation slides

Presenting Author:

Daniel Himmelstein, University of Pennsylvania
05:40 pm 05:50 pm OP 29
Landmark and Cancer-Relevant Gene Selection of RNA Sequencing Data for Survival Analysis

• presentation slides

Presenting Author:
Carly Clayman, Penn State University - Great Valley
05:50 pm 06:00 pm OP 30
The impact of undesired technical variability on large-scale data compendia

• presentation slides

Presenting Author:
Alexandra Lee, Genomics and Computational Biology Graduate Program, University of Pennsylvania, Philadelphia, PA, USA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania,
06:00 pm 06:30 pm Open Ballroom divider wall, move chairs and boards to accommodate Poster Session
     
06:30 pm 08:30 pm Poster Session
- top -
SATURDAY – December 7, 2019
START TIME END TIME SESSION TYPE
08:00 am 11:00 am Registration
08:00 am 09:00 am Breakfast
09:00 am 09:30 am Keynote 7
HEINRICH RÖDER, PhD
Biodesix, Inc.
Colorado, USA

• presentation slides

Development of Clinically Relevant Tests from Human Serum Samples: A Look at the Circulating Proteome
09:30 am 09:40 am OP 31
A pedigree-level examination of Schistosoma japonicum following schistosomiasis reemergence in rural China

• presentation slides

Presenting Author:
Laura Timm, University of Colorado - Anschutz Medical Campus
09:40 am 09:50 am OP 32
High Resolution Proteomics and Genomics of CNDP1 Repeat Variants Linked to Diabetic Nephropathy

• presentation slides

Presenting Author:
Nicholas Kinney, Edward Via College of Osteopathic Medicine
09:50 am 10:00 am OP 33
Computational Analysis of Kinesin Mutations Implicated in Hereditary Spastic Paraplegias

• presentation slides

Presenting Author:
Shaolei Teng, Howard University
10:00 am 10:10 am OP 34
Enabling structure-based data-driven selection of targets for cancer immunotherapy

• presentation slides

Presenting Author:
Dinler Antunes, Rice University
10:10 am 10:20 am OP 35
Biotherapeutic Protein Immunogenicity Risk Assessment with TCPro

• presentation slides

Presenting Author:
Osman Yogurtcu, FDA
10:20 am 10:40 am Break
10:40 am 10:50 am OP 36
Large-scale phylogenetic analysis reveals different sequence divergence patterns in orthologous and paralogous proteins

• presentation slides

Presenting Author:
Joseph Ahrens, University of Colorado Denver Anschutz Medical Campus
10:50 am 11:00 am OP 37
A new framework for clustering single cell RNA-seq data

• presentation slides

Presenting Author:
Ziyou Ren, Northwestern University
11:00 am 11:10 am OP 38
How to annotate what we don’t know

• presentation slides

Presenting Author:

Mayla Boguslav, University of Colorado Anschutz Medical Campus
11:10 am 11:20 am OP 39
Filtering, classification, and selection of new knowledge for model assembly and extension


Presenting Author:
Natasa Miskov-Zivanov, University of Pittsburgh
11:20 am 11:30 am OP 40
Pathway-based Single-Cell RNA-Seq Classification, Clustering, and Construction of Gene-Gene Interactions Networks Using Random Forests

• presentation slides

Presenting Author:
Herbert Pang, University of Hong Kong
11:30 am 12:00 pm Keynote 8
KIRK E. JORDAN, Ph.D.
IBM Distinguished Engineer
Data Centric Solutions
IBM T.J. Watson Research
and
Chief Science Officer
IBM Research UK

Intelligent Simulations - Incorporating AI into Computational Simulations
12:00 pm 12:15 pm Closing Raffle and Awards

 


- top -

Oral Presentations – List


Oral Presentations will be posted on Monday, October 28.

 

 

 

 

Oral Presentations – Abstracts


Oral Presentations will be posted on Monday, October 28.

 

 

 

 

KEYNOTE SPEAKERS


Links within this page:
Joseph Allison
Kevin Bretonnel Cohen
Justin Guinney
Joyce C. Ho
Kirk E. Jordan
Oluwatosin Oluwadare
Heinrich Röder
• Joint Presentation: Nimisha Schneider and Ted Foss

JOSEPH ALLISON, PhD JOSEPH ALLISON, PhD
Bioinformatic Scientist
SomaLogic, Inc.
Colorado, USA

Biography (web)

A Story of Proteomic Statistical Process Control at SomaLogic

The processes that have been implemented to support and run the SomaScan® Assay at SomaLogic are incredibly robust but, before the introduction of Umbrella, post-hoc tracking of these processes and their longitudinal stability was spread across the collective consciousness. Umbrella is a bespoke full-stack data science platform designed to coalesce that collective knowledge and report back to the company at large. These reports range from simple control charting to unsupervised ML pipelines to detect nuanced assay artifact, identify potential causes, and document the impact on our SOMAmer® reagents’ signals. It is this system that enables us to be able to robustly distinguish between biological signal and assay artifact.

- top -

KEVIN BRETONNEL COHEN, PhD KEVIN BRETONNEL COHEN, PhD
Director, Biomedical Text Mining Group
Computational Bioscience Program
University of Colorado School of Medicine
USA

Biography (web)

Two Existential Threats to Biomedical Text Mining...and How to Address Them with Natural Language Processing

The reproducibility crisis calls into question some of the most fundamental use cases of biomedical natural language processing: if 65% of the scientific literature is questionable, what is the point of mining it? Meanwhile, computational research has mostly been immune to the crisis, but there is no a priori reason to expect that state of affairs to continue. This talk proposes that natural language processing itself can address this issue on both fronts--but how?

- top -

JUSTIN GUINNEY, PhD

JUSTIN GUINNEY, PhD
VP, Computational Oncology, Sage Bionetworks
Affiliate Associate Professor, University of Washington
Director, DREAM Challenges
Washington, USA

Biography (web)

The Model-to-Data Paradigm: Overcoming Data Access Barriers in Biomedical Competitions

Data competitions often rely on the physical distribution of data to challenge participants, a significant limitation given that much data is proprietary, sensitive, and often non-shareable. To address this, the DREAM Challenges has advanced a challenge framework called model-to-data (M2D), requiring participants to submit re-runnable algorithms instead of model predictions. The DREAM organization has successfully completed multiple M2D-based challenges, and is expanding this approach to unlock highly sensitive and non-distributable human data for use in biomedical data challenges.

The EHR DREAM Challenges is the first M2D data utilizing EHR data. We are asking participants to predict patient mortality within six months of their last hospital visit, using data from the University of Washington Medical System enterprise data warehouse (2009-2019) with over 1.3 million patients and 22 million visits. Given the highly sensitive nature of EHR data and risks of re-identifiability, the M2D approach is being used to ensure data privacy and protections.

Prior to launching the EHR Challenge, we completed a feasibility study and developed 3 models: demographic information; demographic information and 4 common chronic diseases, and demographic information and the top 20 indications. Model performance using area under the receiver-operating-curve was 0.682, 0.794, and 0.723, respectively. This demonstrated technical robustness of the challenge architecture, and the ability to generate and evaluate predictive algorithms in a secure manner. The EHR Challenge was launched in September 2019, and will close in January 2020.

- top -


JOYCE HO, PhD

JOYCE C. HO, PhD
Assistant Professor, Computer Science Department
Emory University
Georgia, USA

CV (.pdf)

Developing an Evidence Matching Framework Using Web-based Medical Literature

Researchers are discovering new disease subgroups from secondary analyses of electronic health records. However, such subgroups need to be validated or aligned with current literature. We developed a scalable framework that produces evidence sets (or relevant articles) using a large corpus of online medical literature. In this talk, I will discuss some of the challenges associated with term representation and mining biomedical text. I will also present a case study of our framework to validate EHR-based phenotypes.

- top -


KIRK E. JORDAN, Ph.D.

KIRK E. JORDAN, Ph.D.
IBM Distinguished Engineer
Data Centric Solutions
IBM T.J. Watson Research
and
Chief Science Officer
IBM Research UK


Biography: web

Intelligent Simulations - Incorporating AI into Computational Simulations

We are at an inflexion point in the way we are computing today and the way we will compute tomorrow.  While computer systems will consist of heterogeneous components adding to complexity we need to make high end systems much more accessible.   Combine this machine complexity with the fact that more compute is required to tackle the ever increasing complexity of the problems and data that are driving science investigations especially in the life sciences.  How will we address this ever increasing complexity.  IBM Research is looking at the Future of Computing through a new lens which consists of bits, neurons and qubits.  In this talk I will describe how IBM Research is looking at the future of computing and I will outline how we are increasing the use of Artificial Intelligence (AI) and Machine Learning (ML) to address some of the complexity while enabling  us to tackle the interesting science questions we and our collaborators are currently investigating with some examples in the Life Sciences.

- top -


 OLUWATOSIN OLUWADARE, PhD OLUWATOSIN OLUWADARE, PhD
Assistant Professor

Department of Computer Science and Bachelor of Innovation
College of Engineering and Applied Science
University of Colorado
USA

CV (.pdf)

3D Chromosome and Genome Structure Modeling

To improve the understanding of chromosome organization within a cell, chromosome conformation capture techniques such as 3C, 4C, 5C, and Hi-C have been developed. These technologies help to determine the spatial positioning and interaction of genes and chromosome regions within a genome. Using next-generation sequencing strategies such as high-throughput and parallel sequencing, Hi-C can profile read pair interactions on an "all-versus-all" basis—that is, it can profile interactions for all read pairs in an entire genome. The development of chromosome conformation capture techniques, particularly Hi-C, has substantially benefited the study of the spatial proximity, interaction, and genome organization of several cells. In recent years, numerous genome structure construction algorithms have been developed to explain the roles of three-dimensional (3D) structure reconstruction in the cell and to explain abnormalities occurring in a diseased and a normal cell. Three-dimensional inference involves the reconstruction of a genome’s 3D structure or (in some cases) ensemble of structures from contact interaction frequencies represented in a two-dimensional matrix. To solve this 3D inference problem, we developed an optimization-based algorithm that performed better than any existing tool for chromosome and genome 3D structure prediction called 3DMax. 3DMax has been packaged as a software tool and is publicly available to the research community. 3DMax performs well with noisy data; also, its performance is unaffected by changing normalization methods, which is not the case for many other existing methods.

- top -

HEINRICH RÖDER, PhD

HEINRICH RÖDER, PhD
Biodesix, Inc.
Colorado, USA

Biography (web)

Development of Clinically Relevant Tests from Human Serum Samples: A Look at the Circulating Proteome

Therapeutics for the treatment of cancer patients have been transformed with the introduction of immunotherapies, starting with checkpoint inhibition. Instead of targeting the tumor itself, the mechanism of action for immunotherapies relies on reactivation of the immune system such that the host can re-engage the cancer using the complex system evolutionarily developed to heal human disease. In oncology, clinical trials have proven that immunotherapies are effective at reducing tumor burden and extending survival in cancer patients across many indications. However, not all patients benefit from all immunotherapies. Specifically, there is a subgroup of patients whose lack of response may be attributed to a compromised immune system referred to as primary immunotherapy resistance (PIR). A test identifying patients with PIR, prior to treatment with specific immunotherapies, would be useful for guiding therapeutic decision making.

Biodesix uses a hypothesis-free approach to build clinically relevant tests allowing the creation of multivariate classifiers related to deep learning that reflect the complexity of biological interactions without any bias from expectations about their mechanisms. Mass spectral data collected from human serum samples are analyzed by the Diagnostic Cortex® robust data analytics machine learning based platform to design classifiers with clinical relevance. Using this approach, we have developed multiple independently validated tests to identify patients with melanoma and lung cancer that have particular poor outcomes on anti-PD1 immunotherapy and therefore may be unsuitable candidates for treatment with checkpoint inhibition.

These tests stratify patients into different immunological phenotypes with different outcomes on immunotherapies. We applied ideas similar to GSEA (Gene Set Enrichment Analysis) to mass spectral data (PSEA: Protein Set Enrichment Analysis) to gain biological insight into the processes detectable in the circulating proteome related to these phenotypes. We found host immunological functions, such as acute phase response, wound healing, and complement system are related to test classification labels indicating that treatment success does not depend solely on a single molecule, protein, or signaling pathway. Our systems biology approach combining proteomics and machine learning methods is hypothesis generating and requires further external validation; however, our findings have been supported by independent research groups using orthogonal approaches.

- top -

JOINT PRESENTATION:
 
NNIMISHA SCHNEIDER, PhDIMISHA SCHNEIDER, PhD
QuartzBio, part of Precision for Medicine
Maryland, USA

Biography (.pdf)
  TED FOSS, PhDTED FOSS, PhD
Director, Systems and Data Integration
Precision For Medicine
QuartzBio, part of Precision for Medicine
Maryland, USA

LinkedIn profile (web)

Coupling Data-Driven and Mechanistic Modeling Approaches Through the Application of a Scalable, Knowledge-Driven Framework and High-Throughput Public Omics Data Sources

Advances in high throughput measurement technologies (-omics data) have made it possible, and increasingly affordable, to generate high complexity, high volume data for medical research, and these data are increasingly available to researchers through public sources.  Rapidly mining these data for useful mechanistic insights can be a challenge, given their complexity; for example, the cancer genome atlas contains multi-omic and clinical profiles of 11K+ patients across 33 cancer subtypes, over 500K files and 1 billion measurements. This talk will outline (1) how we are building the infrastructure and methods that couple data-driven approaches with a knowledgebase to enable mechanistic modeling of public data sources, (2) the challenges we face when modeling these kinds of data e.g., overfitting of models due to large feature sets on small sample sizes, and (3) a case study on one approach where we mined TCGA for mechanistic insights.
   
- top -  

POSTER SESSION INFORMATION







POSTER SESSION HOURS

The Poster Session with authors present will be on Friday evening. Poster Presenters must be available for presentation during the scheduled poster session.

POSTER NUMBER ASSIGNMENTS
Posters will be assigned even and odd numbers for presentation times. Please put your poster on the poster board corresponding to the number assigned:


POSTER SIZE
The poster board dimensions are 4 feet high x 4 feet wide. Tacks will be provided for securing your poster to the board.


Schedule:

DAY/DATE TIME ACTIVITY/LOCATION
Friday:
December 6
12:00 pm – 06:00 pm SET UP POSTERS
(Maximum size 4 feet high
x 4 feet wide)

Location: Viceroy Hotel Ballroom
Friday:
December 6
06:30 pm – 08:30 pm POSTER SESSION
Location:
Viceroy Hotel Ballroom
06:30 pm – 07:30 pm Authors with Even Number Posters Present
07:30 pm – 08:30 pm Authors with Odd Number Posters Present
08:30 pm Authors please remove posters from boards at end of this session


FURTHER QUESTIONS

Rocky Conference Coordinator
Stephanie Hagstrom
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1 352-665-1763


- top -

AGENDA AT A GLANCE


Go directly to: Friday - December 6 | Saturday - December 7
WEDNESDAY – December 4, 2019
START TIME END TIME SESSION TYPE
04:00 pm 06:00 pm Registration
 
THURSDAY – December 5, 2019
START TIME END TIME SESSION TYPE
08:00 am 06:00 pm Registration
08:00 am 09:00 am Breakfast
09:00 am 09:45 am Keynote 1
KEVIN BRETONNEL COHEN, PhD
Director, Biomedical Text Mining Group
Computational Bioscience Program
University of Colorado School of Medicine, USA

Two Existential Threats to Biomedical Text Mining...and How to Address Them with Natural Language Processing
09:45 am 10:25 am OP 01 - OP 04
10:25 am 10:45 am Break
10:45 am 11:15 am Keynote 2
JOSEPH ALLISON, PhD
Bioinformatic Scientist
SomaLogic, Inc.
Colorado, USA


A Story of Proteomic Statistical Process Control at SomaLogic
11:15 am 11:55 am OP 05 - OP 08
12:00 pm 04:00 pm -->Ski Break
04:00 pm 04:30 pm Keynote 3
OLUWATOSIN OLUWADARE, PhD
Assistant Professor
Department of Computer Science and Bachelor of Innovation
College of Engineering and Applied Science
University of Colorado
USA

3D Chromosome and Genome Structure Modeling 
04:30 pm 05:10 pm OP 09 - OP 12
05:10 pm 05:30 pm Break
05:30 pm 06:00 pm OP 13 - OP 15
06:30 pm 09:30 pm Dinner - Il Poggio
- top -
FRIDAY – December 6, 2019
START TIME END TIME SESSION TYPE
08:00 am 06:00 pm Registration
08:00 am 09:00 am Breakfast
09:00 am 09:45 am Keynote 4
JOYCE C. HO, PhD
Assistant Professor
Computer Science Department
Emory University
Georgia, USA

Developing an Evidence Matching Framework Using Web-based Medical Literature
09:45 am 10:25 am OP 16 - OP 19
10:25 am 10:45 am Break
10:45 am 11:15 am Keynote 5
Joint Presentation:

NIMISHA SCHNEIDER, PhD
QuartzBio, part of
Precision for Medicine
Maryland, USA

TED FOSS, PhD
Director, Systems and Data Integration
Precision For Medicine
QuartzBio, part of Precision for Medicine
Maryland, USA

Coupling Data-Driven and Mechanistic Modeling Approaches Through the Application of a Scalable, Knowledge-Driven Framework and High-Throughput Public Omics Data Sources
11:15 am 11:55 am OP 20 - OP 23
12:00 pm 04:00 pm -->Ski Break
04:00 pm 04:30 pm Keynote 6
JUSTIN GUINNEY, PhD
VP, Computational Oncology
Sage Bionetworks
Affiliate Associate Professor
University of Washington
Director, DREAM Challenges
Washington, USA

The Model-to-Data Paradigm: Overcoming Data Access Barriers in Biomedical Competitions

04:30 pm 05:10 pm OP 24 - OP 27
05:10 pm 05:30 pm Break
05:30 pm 06:00 pm OP 28 - OP 30
06:00 pm 06:30 pm Open Ballroom divider wall, move chairs and boards to accommodate Poster Session
06:30 pm 08:30 pm Poster Session
- top -
SATURDAY – December 7, 2019
START TIME END TIME SESSION TYPE
08:00 am 11:00 am Registration
08:00 am 09:00 am Breakfast
09:00 am 09:30 am Keynote 7
HEINRICH RÖDER, PhD

Biodesix, Inc.
Colorado, USA

Development of Clinically Relevant Tests from Human Serum Samples: A Look at the Circulating Proteome
09:30 am 10:20 am OP 31 - OP 35
10:20 am 10:40 am Break
10:40 am 11:30 am OP 36 - OP 40
11:30 am 12:00 pm Keynote 8
KIRK E. JORDAN, Ph.D.
IBM Distinguished Engineer
Data Centric Solutions
IBM T.J. Watson Research
and
Chief Science Officer
IBM Research UK

Intelligent Simulations - Incorporating AI into Computational Simulations
12:00 pm 12:15 pm Closing Raffle and Awards

 


- top -

Exclusively for members

  • Member Discount

    ISCB Members enjoy discounts on conference registration (up to $150), journal subscriptions, book (25% off), and job center postings (free).

  • Why Belong

    Connecting, Collaborating, Training, the Lifeblood of Science. ISCB, the professional society for computational biology!

     

Supporting ISCB

Donate and Make a Difference

Giving never felt so good! Considering donating today.